Considered as a thyroid oncogenic pathway, AKT/mTOR pathway is mostly hyperactivated in PTC, particularly in poorly differentiated thyroid cancer 31. This evidence concerns the gene AKT1 and poorly differentiated thyroid gland carcinoma.